Key result
MYH7 p.Arg870His variant linked to highly variable HCM phenotypes ranging from asymptomatic to early death.
Why the study?
Information on the clinical variability and modifying factors of the recurrent p.Arg870His variant in MYH7 among hypertrophic cardiomyopathy patients needed synthesis to clarify pathogenicity and inform treatment strategies.
The p.Arg870His variant in the MYH7 gene is associated with highly variable phenotypic manifestations in hypertrophic cardiomyopathy, highlighting the need to understand modifying factors for clinical management.
Answers are grounded in this paper and cite their sources.
Phenotypic variability in p.Arg870His carriers cautions against uniform prognosis; leaves open identification of modifiers.
The review analyzes variability of clinical manifestations of p.Arg870His in the MYH7 gene, which is repeatedly registered in patients with hypertrophic cardiomyopathy (HCM). The analysis involves the data from scientific publications obtained as a search result in the PubMed, СlinVar, and eLibrary.ru databases, as well as authors’ own results. A wide range of phenotypic manifestations have been revealed in carriers of p.Arg870His, from the asymptomatic to severe course, rapid progression, and early death. The review considers possible factors that modify the effect of the pathogenic variant (i.e. dosage of the pathogenic variant, the presence of other unfavorable genetic variants, etc.). The importance of accumulating information on the clinical features of HCM in the carriers of specific gene variants is emphasized in order to clarify their pathogenicity and to identify factors modifying the clinical outcome, which is important for the choice of the treatment strategy for HCM.
No takes yet. Share an insight, caveat, or question.
Кучер et al. (2022) conducted a review in Hypertrophic cardiomyopathy. p.Arg870His pathogenic variant in the MYH7 gene was evaluated on Phenotypic manifestations. Carriers of the p.Arg870His pathogenic variant in the MYH7 gene exhibit a wide range of phenotypic manifestations of hypertrophic cardiomyopathy, from asymptomatic to severe course and early death.
Synapse has enriched 10 related papers. Consider them for comparative context: